Eva Bandres

Pamplona, NC 31008, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Identification and Extension of the HLA-B*40:283 Allele Sequence.

Identification and Extension of the HLA-B*40:283 Allele Sequence.

Journal: HLA
Published: June 05, 2026

Identification of a Novel HLA-DPA1 Allele With a New Amino Acid Residue in the Core Domain, HLA-DPA1*01:249.

Identification of a Novel HLA-DPA1 Allele With a New Amino Acid Residue in the Core Domain, HLA-DPA1*01:249.

Journal: HLA
Published: February 05, 2026

Identification of a Novel HLA-C Allele With a New Amino Acid Residue in the α-3 Domain, HLA-C*07:1216.

Identification of a Novel HLA-C Allele With a New Amino Acid Residue in the α-3 Domain, HLA-C*07:1216.

Journal: HLA
Published: September 02, 2025

Characterization of the novel HLA-DQA1*01:133Q allele with one amino acid deletion in the alpha-3 domain.

Characterization of the novel HLA-DQA1*01:133Q allele with one amino acid deletion in the alpha-3 domain.

Journal: HLA
Published: October 02, 2023

Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects.

Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects.

Journal: Life science alliance
Published: October 07, 2022

"Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain".

"Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain".

Journal: Human immunology
Published: August 29, 2022

Identification of two HLA-C alleles with new amino acid residues in the α-3 domain, HLA-C*03:581 and -C*05:267.

Identification of two HLA-C alleles with new amino acid residues in the α-3 domain, HLA-C*03:581 and -C*05:267.

Journal: HLA
Published: December 16, 2021

Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.

Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.

Journal: International journal of molecular sciences
Published: June 21, 2021

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms.

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms.

Journal: Journal of clinical medicine
Published: November 02, 2020

Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET.

Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 26, 2020

Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression.

Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression.

Journal: British journal of haematology
Published: October 07, 2019

Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients.

Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients.

Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: June 25, 2016
Showing 1-12 of 22

Last Updated: 09/26/2026